Literature DB >> 31411534

The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease.

Ece Bayram1, Nikki Kaplan2, Guogen Shan3, Jessica Z K Caldwell2.   

Abstract

Cognitive decline and mood symptoms are common in Parkinson's disease (PD). Reductions in striatal dopaminergic binding have been associated with worse cognition and mood. We investigated whether this association persists throughout the disease progression in newly diagnosed PD. Four-year data from Parkinson's Progression Markers Initiative (PPMI) were used. Groups consisted of left and right limb dominantly affected PD patients, and controls. Longitudinal relationships between cognition, mood and striatal binding ratios were assessed by repeated measures correlations. Reduced binding was associated with general cognitive decline in controls, reduced processing speed and increased mood symptoms in PD. Anxiety was associated with striatum only in left limb dominantly affected PD. Dominantly affected limb side did not impact striatum and cognition association. There are longitudinal associations between striatum, processing speed and anxiety. Dopamine transporter availability imaging may have some prognostic value for cognition and mood in PD.

Entities:  

Keywords:  Parkinson’s disease; cognition; dopamine; mood; striatum

Mesh:

Substances:

Year:  2019        PMID: 31411534      PMCID: PMC8763139          DOI: 10.1080/13825585.2019.1653445

Source DB:  PubMed          Journal:  Neuropsychol Dev Cogn B Aging Neuropsychol Cogn        ISSN: 1382-5585


  32 in total

1.  Age differences in the frontal lateralization of verbal and spatial working memory revealed by PET.

Authors:  P A Reuter-Lorenz; J Jonides; E E Smith; A Hartley; A Miller; C Marshuetz; R A Koeppe
Journal:  J Cogn Neurosci       Date:  2000-01       Impact factor: 3.225

2.  DaTscan and Parkinson's disease: DAT binding should not lead to binding decisions in clinical practice.

Authors:  R de la Fuente-Fernández; K-O Lövblad
Journal:  Eur J Neurol       Date:  2014-05-17       Impact factor: 6.089

3.  Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease.

Authors:  Seok Jong Chung; Han Soo Yoo; Jungsu S Oh; Jae Seung Kim; Byoung Seok Ye; Young H Sohn; Phil Hyu Lee
Journal:  Parkinsonism Relat Disord       Date:  2018-03-02       Impact factor: 4.891

4.  Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus.

Authors:  A Brück; R Portin; A Lindell; A Laihinen; J Bergman; M Haaparanta; O Solin; J O Rinne
Journal:  Neurosci Lett       Date:  2001-09-28       Impact factor: 3.046

5.  Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]beta-CIT SPECT.

Authors:  G Tissingh; P Bergmans; J Booij; A Winogrodzka; E A van Royen; J C Stoof; E C Wolters
Journal:  J Neurol       Date:  1998-01       Impact factor: 4.849

6.  Cognitive slowing in Parkinson disease is accompanied by hypofunctioning of the striatum.

Authors:  N Sawamoto; M Honda; T Hanakawa; T Aso; M Inoue; H Toyoda; K Ishizu; H Fukuyama; H Shibasaki
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

7.  Role of DaTSCAN and clinical diagnosis in Parkinson disease.

Authors:  Raúl de la Fuente-Fernández
Journal:  Neurology       Date:  2012-02-08       Impact factor: 9.910

8.  Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

Authors:  Daniel Weintraub; Andrew B Newberg; Mark S Cary; Andrew D Siderowf; Paul J Moberg; Galit Kleiner-Fisman; John E Duda; Matthew B Stern; David Mozley; Ira R Katz
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

9.  The early course of affective and cognitive symptoms in de novo patients with Parkinson's disease.

Authors:  Gianfranco Spalletta; Robert G Robinson; Luca Cravello; Francesco E Pontieri; Mariangela Pierantozzi; Alessandro Stefani; Jeffrey D Long; Carlo Caltagirone; Francesca Assogna
Journal:  J Neurol       Date:  2014-04-03       Impact factor: 4.849

10.  Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

Authors:  Philippe Remy; Miroslava Doder; Andrew Lees; Nora Turjanski; David Brooks
Journal:  Brain       Date:  2005-02-16       Impact factor: 13.501

View more
  7 in total

1.  Partial correlation coefficient for a study with repeated measurements.

Authors:  Guogen Shan; Ece Bayram; Jessica Z K Caldwell; Justin B Miller; Jay J Shen; Shawn Gerstenberger
Journal:  Stat Biopharm Res       Date:  2020-07-20       Impact factor: 1.452

2.  Characterization of Parkinson's Disease Subtypes and Related Attributes.

Authors:  Shamatree Shakya; Julia Prevett; Xiao Hu; Ran Xiao
Journal:  Front Neurol       Date:  2022-05-23       Impact factor: 4.086

Review 3.  Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review.

Authors:  Guillaume Carey; Meltem Görmezoğlu; Joost J A de Jong; Paul A M Hofman; Walter H Backes; Kathy Dujardin; Albert F G Leentjens
Journal:  Mov Disord       Date:  2020-12-02       Impact factor: 10.338

4.  Structural and Functional Alterations of Substantia Nigra and Associations With Anxiety and Depressive Symptoms Following Traumatic Brain Injury.

Authors:  Liang Gao; Qiang Xue; Shun Gong; Gaoyi Li; Wusong Tong; Mingxia Fan; Xianzhen Chen; Jia Yin; Yu Song; Songyu Chen; Jingrong Huang; Chengbin Wang; Yan Dong
Journal:  Front Neurol       Date:  2022-04-05       Impact factor: 4.003

Review 5.  Shared gray matter alterations in subtypes of addiction: a voxel-wise meta-analysis.

Authors:  Mengzhe Zhang; Xinyu Gao; Zhengui Yang; Mengmeng Wen; Huiyu Huang; Ruiping Zheng; Weijian Wang; Yarui Wei; Jingliang Cheng; Shaoqiang Han; Yong Zhang
Journal:  Psychopharmacology (Berl)       Date:  2021-07-27       Impact factor: 4.530

6.  Semantic fluency and processing speed are reduced in non-cognitively impaired participants with Parkinson's disease.

Authors:  Brenna A Cholerton; Kathleen L Poston; Laurice Yang; Liana S Rosenthal; Ted M Dawson; Alexander Pantelyat; Karen L Edwards; Lu Tian; Joseph F Quinn; Kathryn A Chung; Amie L Hiller; Shu-Ching Hu; Thomas J Montine; Cyrus P Zabetian
Journal:  J Clin Exp Neuropsychol       Date:  2021-08-06       Impact factor: 2.283

7.  Correlation Coefficients for a Study with Repeated Measures.

Authors:  Guogen Shan; Hua Zhang; Tao Jiang
Journal:  Comput Math Methods Med       Date:  2020-03-26       Impact factor: 2.238

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.